New Key Statistics Module, Z-Score and F-Score
NAS:CHRS Key Ratios
Market Cap $ M | 253.81 |
Enterprise Value $ M | 460.02 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 0.78 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 301.00 |
EPS (TTM) $ | -0.81 |
Beneish M-Score | -1.4 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -26.81 |
EV-to-EBITDA | -35.53 |
PEG | -- |
Shares Outstanding M | 114.73 |
Net Margin (%) | -19.64 |
Operating Margin % | -58.96 |
Pre-tax Margin (%) | -19.77 |
Quick Ratio | 1.05 |
Current Ratio | 1.17 |
ROA % (ttm) | -10.41 |
ROE % (ttm) | -- |
ROIC % (ttm) | -79.17 |
Dividend Yield % | -- |
Altman Z-Score | -2.08 |
CHRS Number of Guru Trades
CHRS Volume of Guru Trades
Gurus Latest Trades with NAS:CHRS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CHRS is held by these investors
Total 1
Coherus BioSciences Inc Insider Transactions
No Available Data
News about NAS:CHRS
Total 0- 1